594 related articles for article (PubMed ID: 30818749)
1. Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients under Long-Term ART.
Zicari S; Sessa L; Cotugno N; Ruggiero A; Morrocchi E; Concato C; Rocca S; Zangari P; Manno EC; Palma P
Viruses; 2019 Feb; 11(3):. PubMed ID: 30818749
[TBL] [Abstract][Full Text] [Related]
2. Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.
Hsu DC; Sereti I
Drugs; 2016 Apr; 76(5):533-49. PubMed ID: 26915027
[TBL] [Abstract][Full Text] [Related]
3. Managing HIV-associated inflammation and ageing in the era of modern ART.
Bloch M; John M; Smith D; Rasmussen TA; Wright E
HIV Med; 2020 Oct; 21 Suppl 3():2-16. PubMed ID: 33022087
[TBL] [Abstract][Full Text] [Related]
4. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.
Babu H; Ambikan AT; Gabriel EE; Svensson Akusjärvi S; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
Front Immunol; 2019; 10():1965. PubMed ID: 31507593
[TBL] [Abstract][Full Text] [Related]
5. What happens to cardiovascular system behind the undetectable level of HIV viremia?
d'Ettorre G; Ceccarelli G; Pavone P; Vittozzi P; De Girolamo G; Schietroma I; Serafino S; Giustini N; Vullo V
AIDS Res Ther; 2016; 13():21. PubMed ID: 27127532
[TBL] [Abstract][Full Text] [Related]
6. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
7. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
Front Immunol; 2019; 10():1378. PubMed ID: 31275317
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
9. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
10. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
Deeks SG
Top HIV Med; 2009; 17(4):118-23. PubMed ID: 19890183
[TBL] [Abstract][Full Text] [Related]
11. HIV and inflammation: mechanisms and consequences.
Hunt PW
Curr HIV/AIDS Rep; 2012 Jun; 9(2):139-47. PubMed ID: 22528766
[TBL] [Abstract][Full Text] [Related]
12. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, Immune Activation, and Antiretroviral Therapy in HIV.
Hileman CO; Funderburg NT
Curr HIV/AIDS Rep; 2017 Jun; 14(3):93-100. PubMed ID: 28434169
[TBL] [Abstract][Full Text] [Related]
14. HIV-related metabolic comorbidities in the current ART era.
Warriner AH; Burkholder GA; Overton ET
Infect Dis Clin North Am; 2014 Sep; 28(3):457-76. PubMed ID: 25151566
[TBL] [Abstract][Full Text] [Related]
15. Assessing inflammation and its role in comorbidities among persons living with HIV.
Peterson TE; Baker JV
Curr Opin Infect Dis; 2019 Feb; 32(1):8-15. PubMed ID: 30461454
[TBL] [Abstract][Full Text] [Related]
16. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
Bandera A; De Benedetto I; Bozzi G; Gori A
Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence.
Willig AL; Overton ET
Curr HIV/AIDS Rep; 2016 Oct; 13(5):289-96. PubMed ID: 27541600
[TBL] [Abstract][Full Text] [Related]
18. Complications of Treatment in Youth with HIV.
Eckard AR; Fowler SL; Haston JC; Dixon TC
Curr HIV/AIDS Rep; 2016 Aug; 13(4):226-33. PubMed ID: 27234970
[TBL] [Abstract][Full Text] [Related]
19. The role of statins in the setting of HIV infection.
Eckard AR; McComsey GA
Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
[TBL] [Abstract][Full Text] [Related]
20. The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-naïve adult HIV-infected patients in gedio-zone, southern Ethiopia: Comparative cross-sectional study, using the Adult Treatment Panel III criteria.
Bune GT; Yalew AW; Kumie A
Diabetes Metab Syndr; 2019; 13(5):2833-2841. PubMed ID: 31425944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
